Tamoxifen metabolism (Homo sapiens)
From WikiPathways
Description
No description
Quality Tags
Ontology Terms
Bibliography
View all... |
- Ogura K, Ishikawa Y, Kaku T, Nishiyama T, Ohnuma T, Muro K, Hiratsuka A; ''Quaternary ammonium-linked glucuronidation of trans-4-hydroxytamoxifen, an active metabolite of tamoxifen, by human liver microsomes and UDP-glucuronosyltransferase 1A4.''; Biochem Pharmacol, 2006 PubMed Europe PMC Scholia
- Jordan VC; ''New insights into the metabolism of tamoxifen and its role in the treatment and prevention of breast cancer.''; Steroids, 2007 PubMed Europe PMC Scholia
- Jordan VC; ''Chemoprevention of breast cancer with selective oestrogen-receptor modulators.''; Nat Rev Cancer, 2007 PubMed Europe PMC Scholia
- Kaku T, Ogura K, Nishiyama T, Ohnuma T, Muro K, Hiratsuka A; ''Quaternary ammonium-linked glucuronidation of tamoxifen by human liver microsomes and UDP-glucuronosyltransferase 1A4.''; Biochem Pharmacol, 2004 PubMed Europe PMC Scholia
- Lazarus P, Blevins-Primeau AS, Zheng Y, Sun D; ''Potential role of UGT pharmacogenetics in cancer treatment and prevention: focus on tamoxifen.''; Ann N Y Acad Sci, 2009 PubMed Europe PMC Scholia
- Jordan VC; ''Fourteenth Gaddum Memorial Lecture. A current view of tamoxifen for the treatment and prevention of breast cancer.''; Br J Pharmacol, 1993 PubMed Europe PMC Scholia
History
View all... |
External references
DataNodes
View all... |
Name | Type | Database reference | Comment |
---|---|---|---|
4-hydroxy-N-desmethyltamoxifen | Metabolite | 3035980 (PubChem-compound) | |
CYP1A1 | GeneProduct | ENSG00000140465 (Ensembl Human) | |
CYP1A2 | GeneProduct | ENSG00000140505 (Ensembl Human) | |
CYP1B1 | GeneProduct | ENSG00000138061 (Ensembl Human) | |
CYP2A6 | GeneProduct | ENSG00000213052 (Ensembl Human) | |
CYP2C19 | GeneProduct | ENSG00000165841 (Ensembl Human) | |
CYP2C8 | GeneProduct | ENSG00000138115 (Ensembl Human) | |
CYP2C9 | GeneProduct | ENSG00000138109 (Ensembl Human) | |
CYP2D6 | GeneProduct | ENSG00000100197 (Ensembl Human) | |
CYP2E1 | GeneProduct | ENSG00000130649 (Ensembl Human) | |
CYP3A4 | GeneProduct | ENSG00000160868 (Ensembl Human) | |
CYP3A5 | GeneProduct | ENSG00000106258 (Ensembl Human) | |
FMO1 | GeneProduct | ENSG00000010932 (Ensembl Human) | |
FMO3 | GeneProduct | ENSG00000007933 (Ensembl Human) | |
Metabolite | Metabolite | ||
N,N-didesmethyltamoxifen | Metabolite | 3036172 (PubChem-compound) | |
N-desmethyltamoxifen | Metabolite | 3032890 (PubChem-compound) | |
PAP | Metabolite | HMDB00061 (HMDB) | |
PAPS | Metabolite | 10214 (PubChem-compound) | |
SSRI | Metabolite | ||
SULT1A1 | GeneProduct | ENSG00000196502 (Ensembl Human) | |
SULT1E1 | GeneProduct | ENSG00000109193 (Ensembl Human) | |
SULT2A1 | GeneProduct | ENSG00000105398 (Ensembl Human) | |
Tamoxifen-N-oxide | Metabolite | ||
UGT1A10 | GeneProduct | 54575 (Entrez Gene) | |
UGT1A4 | GeneProduct | 54657 (Entrez Gene) | |
UGT1A8 | GeneProduct | 54576 (Entrez Gene) | |
UGT2B15 | GeneProduct | ENSG00000197592 (Ensembl Human) | |
UGT2B7 | GeneProduct | 7364 (Entrez Gene) | |
alpha-hydroxy-N-desmethyltamoxifen | Metabolite | ||
alpha-hydroxytamoxifen | Metabolite | ||
cis-4-hydroxy-N-desmethyltamoxifen | Metabolite | ||
cis-4-hydroxytamoxifen | Metabolite | ||
cis-4-hydroxytamoxifen-N-glucuronide | Metabolite | ||
cis-N-desmethyltamoxifen-O-glucuronide | Metabolite | ||
cis-tamoxifen-4-O-glucuronide | Metabolite | ||
deamino-hydroxytamoxifen | Metabolite | 3033897 (PubChem-compound) | |
tamoxifen-N-glucuronide | Metabolite | 5460873 (PubChem-compound) | |
trans-4-Sulfoxytamoxifen | Metabolite | ||
trans-4-hydroxytamoxifen-N-glucuronide | Metabolite | ||
trans-4-hydroxytamoxifen | Metabolite | 449459 (PubChem-compound) | |
trans-N-desmethyltamoxifen-O-glucuronide | Metabolite | ||
trans-tamoxifen-4-O-glucuronide | Metabolite | ||
trans-tamoxifen | Metabolite | HMDB12287 (HMDB) |
Annotated Interactions
No annotated interactions